Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,026.10
+12.60 (1.24%)
At close: Dec 5, 2025
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 553.91 billion as of December 5, 2025. Its market cap has increased by 111.39% in one year.
Market Cap
553.91B
Enterprise Value
576.68B
Revenue
63.58B
Ranking
n/a
PE Ratio
81.01
Stock Price
1,026.10
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 553.91B, an increase of 1,067.66%. That is a compound annual growth rate of 31.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 547.11B | 68.34% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | 189.50B | 392.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 940.78B |
| Mankind Pharma | 910.38B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |